The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Loss-of-function mutations of CHST14 in a new type of Ehlers-Danlos syndrome
Open accessAbstract
Ehlers-Danlos syndrome (EDS) is a heterogeneous connective tissue disorder involving skin and joint laxity and tissue fragility. A new type of EDS, similar to kyphoscoliosis type but without lysyl hydroxylase deficiency, has been investigated. We have identified a homozygous CHST14 (carbohydrate sulfotransferase 14) mutation in the two familial cases and compound heterozygous mutations in four sporadic cases. CHST14 encodes dermatan 4-O-sulfotransferase 1 (D4ST1), which transfers active sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 4 of the N-acetyl-D-galactosamine (GalNAc) residues of dermatan sulfate (DS). Transfection experiments of mutants and enzyme assays using fibroblast lysates of patients showed the loss of D4ST1 activity. CHST14 mutations altered the glycosaminoglycan (GAG) components in patients' fibroblasts. Interestingly, DS of decorin proteoglycan, a key regulator of collagen fibril assembly, was completely lost and replaced by chondroitin sulfate (CS) in the patients' fibroblasts, leading to decreased flexibility of GAG chains. The loss of the decorin DS proteoglycan due to CHST14 mutations may preclude proper collagen bundle formation or maintenance of collagen bundles while the sizes and shapes of collagen fibrils are unchanged as observed in the patients' dermal tissues. These findings indicate the important role of decorin DS in the extracellular matrix and a novel pathomechanism in EDS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Miyake et al. [2010] identified CHST14 as the causal gene for this condition through homozygosity mapping using the two consanguineous families.”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
In the citing paper
“GAG chains of decorin from the affected skin fibroblasts contained exclusively CS and no DS disaccharides, while those from the controls contained mainly DS disaccharides (approximately 95%)”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
In the citing paper
“Transmission electron microscopy showed that collagen fibrils in the affected skin specimens were dispersed in the reticular dermis in contrast to the regularly and tightly assembled collagen fibrils observed in the controls and that each collagen fibril in affected skin specimens was smooth and round, not varying in size and shape, similar to that in the controls”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
In the citing paper
“Light microscopy of the affected skin specimens using hematoxylin and eosin staining showed that fine collagen fibers were predominantly present in the reticular to papillary dermis with marked reduction of normally thick collagen bundles”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
In the citing paper
“Disaccharide composition analysis of CS/DS chains isolated from the affected skin fibroblasts in these two patients showed a negligible amount of DS and excess amount of CS, which was suggested to result from impaired 4-O-sulfation lock due to D4ST1 deficiency, followed by backepimerization from IdoA to GlcA”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
In the citing paper
“Sulfotransferase activity toward DS in mutant skin fibroblasts was significantly decreased to 6.7% in a patient with the compound heterozygous mutation p.(Pro281Leu)/p.(TyrY293Cys) and to 14.5% in a patient with the homozygous mutation p.(Pro281Leu), compared with each age-and sex-matched control”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
In the citing paper
“The sulfotransferase activity of cos-7 cells transfected with CHST14 containing p.(LysK69 Ã ), p.(Pro281Leu), p.(Cys289Ser), or p.(Tyr293Cys) mutations was decreased at almost the same level, suggesting that loss-of-function mutations in CHST14 (i.e., D4ST1 deficiency) are the basis of this disorder”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Miyake et al., 2010
Citations
Cites
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility
Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H. K., Kadler, K. E., & Iozzo, R. V. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.3.729 · Cited by 1,407
Purification and Properties of Bacterial Chondroitinases and Chondrosulfatases
Yamagata, T., Saito, H., Habuchi, O., & Suzuki, S. (1968) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)93574-x · Cited by 1,238
Human Smad3 and Smad4 Are Sequence-Specific Transcription Activators
Zawel, L. S., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., & Kern, S. E. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80061-1 · Cited by 940
Leucine-rich repeat glycoproteins of the extracellular matrix
Hocking, A. M., Shinomura, T., & McQuillan, D. J. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90121-4 · Cited by 470
Steinmann, B., Royce, P. M., & Superti‐Furga, A. (2002) · Connective Tissue and Its Heritable Disorders · doi:10.1002/0471221929.ch9 · Cited by 358
Chondroitin/dermatan sulfate in the central nervous system
Sugahara, K., & Mikami, T. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.08.015 · Cited by 280
Self-citationCasu, B., Petitou, M., Provasoli, M., & Sînaÿ, P. (1988) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(88)90088-6 · Cited by 264
Scott, J. E. (1996) · Biochemistry · doi:10.1021/bi960773t · Cited by 246
Scott, J. E. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.050179 · Cited by 245
Flagged first, then by citations
1 of the 35 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Yoshida, 1993, Dermatan sulfate proteoglycans: chemistry, biology, chemical pathology, 55
Cited by
Sorted by citations
Biosynthesis and function of chondroitin sulfate
Mikami, T., & Kitagawa, H. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.006 · Cited by 526
The Ehlers–Danlos syndrome, a disorder with many faces
De Paepe, A., & Malfait, F. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01858.x · Cited by 379
Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders
da Costa, D. S., Reis, R. L., & Pashkuleva, I. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044610 · Cited by 329
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 346
Self-citationThe Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 258
Self-citationCongenital disorders of glycosylation
Chang, I. J., He, M., & Lam, C. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.45 · Cited by 244
Castori, M. (2012) · ISRN Dermatology · doi:10.5402/2012/751768 · Cited by 222
Baumann, M., Giunta, C., Krabichler, B., Rüschendorf, F., Zoppi, N., Colombi, M., Bittner, R. E., Quijano-Roy, S., Muntoni, F., Cirak, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.12.004 · Cited by 162
Gensemer, C., Burks, R., Kautz, S. A., Judge, D. P., Lavallee, M. E., & Norris, R. A. (2020) · Developmental Dynamics · doi:10.1002/dvdy.220 · Cited by 163
Malfait, F., Kariminejad, A., Van Damme, T., Gauche, C., Syx, D., Merhi-Soussi, F., Gulberti, S., Symoens, S., Vanhauwaert, S., Willaert, A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.016 · Cited by 142
Nakajima, M., Mizumoto, S., Miyake, N., Kogawa, R., Iida, A., Ito, H., Kitoh, H., Hirayama, A., Mitsubuchi, H., Miyazaki, O., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.003 · Cited by 137
Self-citationBiological functions of iduronic acid in chondroitin/dermatan sulfate
Thelin, M. A., Bartolini, B., Axelsson, J. B., Gustafsson, R., Tykesson, E., Pera, E. M., Oldberg, Å., Maccarana, M., & Malmström, A. (2013) · FEBS Journal · doi:10.1111/febs.12214 · Cited by 141
Faulty Initiation of Proteoglycan Synthesis Causes Cardiac and Joint Defects
Baasanjav, S., Al‐Gazali, L., Hashiguchi, T., Mizumoto, S., Fischer‐Zirnsak, B., Horn, D., Seelow, D., Ali, B. R., Aziz, S., Langer, R. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.021 · Cited by 131
Self-citationMalfait, F., Syx, D., Vlummens, P., Symoens, S., Nampoothiri, S., Hermanns-Lê, T., Van Laer, L., & De Paepe, A. (2010) · Human Mutation · doi:10.1002/humu.21355 · Cited by 122
Malfait, F., & Paepe, A. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7893-1_9 · Cited by 126
Iduronic Acid in Chondroitin/Dermatan Sulfate
Malmström, A., Bartolini, B., Thelin, M. A., Pacheco, B., & Maccarana, M. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412459857 · Cited by 118
Vascular aspects of the Ehlers-Danlos Syndromes
Malfait, F. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.013 · Cited by 113
SMOC1 Is Essential for Ocular and Limb Development in Humans and Mice
Okada, I., Hamanoue, H., Terada, K., Tohma, T., Mégarbané, A., Chouery, É., Ghoch, J. A., Jalkh, N., Çoğulu, Ö., Özkınay, F., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.11.012 · Cited by 112
Self-citationExpanding the clinical and genetic heterogeneity of hereditary disorders of connective tissue
Alazami, A. M., Al-Qattan, S. M., Faqeih, E., Alhashem, A., Alshammari, M., Alzahrani, F., Al-Dosari, M. S., Patel, N., Alsagheir, A., Binabbas, B., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1660-z · Cited by 110
Mizumoto, S., Ikegawa, S., & Sugahara, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.437038 · Cited by 114
Self-citationThe extracellular matrix of the dermis: flexible structures with dynamic functions
Krieg, T. M., & Aumailley, M. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01313.x · Cited by 124
Nallasamy, S., Yoshida, K., Akins, M. L., Myers, K. M., Iozzo, R. V., & Mahendroo, M. (2017) · Endocrinology · doi:10.1210/en.2016-1930 · Cited by 105
Müller, T., Mizumoto, S., Suresh, I., Komatsu, Y., Vodopiutz, J., Dündar, M., Straub, V. W., Lingenhel, A., Melmer, A., Lechner, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt227 · Cited by 107
Self-citationVissers, L. E. L. M., Lausch, E. U., Unger, S., Campos‐Xavier, B., Gilissen, C., Rossi, A., del Rosario, M., Venselaar, H., Knoll, U., Nampoothiri, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.002 · Cited by 100
Ehlers–Danlos syndrome: how to diagnose and when to perform genetic tests
Sobey, G. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304822 · Cited by 98
Proteoglycans in brain development and pathogenesis
Schwartz, N. B., & Domowicz, M. S. (2018) · FEBS Letters · doi:10.1002/1873-3468.13026 · Cited by 99
Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review
D’hondt, S., Damme, T. V., & Malfait, F. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.138 · Cited by 92
Syx, D., Van Damme, T., Symoens, S., Maiburg, M. C., van de Laar, I., Morton, J., Suri, M., Del Campo, M., Hausser, I., Hermanns-Lê, T., et al. (2015) · Human Mutation · doi:10.1002/humu.22774 · Cited by 84
Mizumoto, S., Fongmoon, D., & Sugahara, K. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9463-5 · Cited by 84
Self-citationAn unbiased evaluation of gene prioritization tools
Börnigen, D., Tranchevent, L.-C., Capdevila, F. B., Devriendt, K., Moor, B. D., Causmaecker, P. D., & Moreau, Y. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts581 · Cited by 81
Golgi Glycosylation and Human Inherited DiseasesPreprint
Freeze, H. H., & Ng, B. G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005371 · Cited by 78
Glycosaminoglycans: Sweet as Sugar Targets for Topical Skin Anti-Aging
Wang, S. T., Neo, B. H., & Betts, R. J. (2021) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s328671 · Cited by 78
Paganini, C., Costantini, R., Superti‐Furga, A., & Rossi, A. (2019) · FEBS Journal · doi:10.1111/febs.14984 · Cited by 74
Ehlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology
Byers, P. H., & Murray, M. L. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.07.005 · Cited by 68
“A third EDS phenotype, the “musculocontractural” type (type VIB), results from mutations in CHST14, which encodes dermatan 4-Osulfotransferase 1(Malfait et al., 2010;Miyake et al., 2010).”
BackgroundShimizu, K., Okamoto, N., Miyake, N., Taira, K., Sato, Y., Matsuda, K., Akimaru, N., Ohashi, H., Wakui, K., Fukushima, Y., et al. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34115 · Cited by 68
Self-citationGlycosaminoglycans are functional ligands for receptor for advanced glycation end‐products in tumors
Mizumoto, S., & Sugahara, K. (2013) · FEBS Journal · doi:10.1111/febs.12156 · Cited by 66
Self-citationThe phenotype of the musculocontractural type of Ehlers‐Danlos syndrome due to CHST14 mutations
Janecke, A. R., Li, B., Boehm, M., Krabichler, B., Rohrbach, M., Müller, T., Fuchs, I., Golas, G., Katagiri, Y., Ziegler, S. G., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37383 · Cited by 66
The Genetics of Soft Connective Tissue Disorders
Vanakker, O. M., Callewaert, B. L., Malfait, F., & Coucke, P. J. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-050039 · Cited by 69
Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests
Sasarman, F., Maftei, C., Campeau, P. M., Brunel‐Guitton, C., Mitchell, G. A., & Allard, P. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9903-z · Cited by 61
Fragility of epidermis and its consequence in dermatology
Stalder, J. ‐., Tennstedt, D., Deleuran, M. S., Fabbrocini, G., de Lucas, R., Haftek, M., TAIEB, C., Coustou, D., Mandeau, A., Fabre, B., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12509 · Cited by 61
Heritable Collagen Disorders: The Paradigm of the Ehlers—Danlos Syndrome
Byers, P. H., & Murray, M. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/skinbio.2012.3 · Cited by 57
Witkos, T. M., Chan, W. L., Joensuu, M., Rhiel, M., Pallister, E. G., THOMAS‐OATES, J. E., Mould, A. P., Mironov, A. A., Biot, C., Guérardel, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08044-6 · Cited by 52
Human genetic disorders and knockout mice deficient in glycosaminoglycan
Mizumoto, S., Yamada, S., & Sugahara, K. (2014) · BioMed Research International · doi:10.1155/2014/495764 · Cited by 54
Self-citationGenetics and pathophysiology of mammalian sulfate biology
Langford, R., Hurrion, E. M., & Dawson, P. A. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.08.001 · Cited by 55
CHST14/D4ST1 deficiency: New form of Ehlers–Danlos syndrome
Kosho, T. (2016) · Pediatrics International · doi:10.1111/ped.12878 · Cited by 53
Self-citationCongenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis
Mizumoto, S., & Yamada, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.717535 · Cited by 58
Self-citationSpatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease
Basu, A., Patel, N. G., Nicholson, E. D., & Weiss, R. J. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00085.2022 · Cited by 53
Minatogawa, M., Unzaki, A., Morisaki, H., Syx, D., Sonoda, T., Janecke, A., Slavotinek, A. M., Voermans, N. C., Lacassie, Y., Mendoza‐Londono, R., et al. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107623 · Cited by 46
Self-citationDermatan 4-O-sulfotransferase1 ablation accelerates peripheral nerve regeneration
Akyüz, N., Rost, S., Mehanna, A., Bian, S., Loers, G., Oezen, I., Mishra, B., Hoffmann, K., Guseva, D., Laczynska, E., et al. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.01.025 · Cited by 46
The Specific Role of Dermatan Sulfate as an Instructive Glycosaminoglycan in Tissue Development
Mizumoto, S., & Yamada, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137485 · Cited by 44
Self-citationEwans, L., Colley, A., Gaston‐Massuet, C., Gualtieri, A., Cowley, M. J., McCabe, M. J., Anand, D., Lachke, S. A., Scietti, L., Forneris, F., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106019 · Cited by 42
Proteoglycans and Their Heterogeneous Glycosaminoglycans at the Atomic Scale
Sattelle, B. M., Shakeri, J., Cliff, M. J., & Almond, A. (2015) · Biomacromolecules · doi:10.1021/bm5018386 · Cited by 41
Nikolovska, K., Renke, J. K., Jungmann, O., Grobe, K., Iozzo, R. V., Zamfir, A. D., & Seidler, D. G. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.003 · Cited by 41
Mizumoto, S., & Yamada, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764781 · Cited by 43
Self-citationThe galactosaminoglycan-containing decorin and its impact on diseases
Seidler, D. G. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.07.012 · Cited by 40
Recent Advances in the Pathophysiology of Musculocontractural Ehlers-Danlos Syndrome
Kosho, T., Mizumoto, S., Watanabe, T., Yoshizawa, T., Miyake, N., & Yamada, S. (2019) · Genes · doi:10.3390/genes11010043 · Cited by 44
Self-citationAkatsu, C., Mizumoto, S., Kaneiwa, T., Maccarana, M., Malmström, A., Yamada, S., & Sugahara, K. (2010) · Glycobiology · doi:10.1093/glycob/cwq208 · Cited by 38
Self-citationHirose, T., Takahashi, N., Tangkawattana, P., MINAGUCHI, J. A., Mizumoto, S., Yamada, S., Miyake, N., Hayashi, S., Hatamochi, A., Nakayama, J., et al. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.12.006 · Cited by 39
Self-citationSkeletal Dysplasias Caused by Sulfation Defects
Paganini, C., Tota, C. G., Superti‐Furga, A., & Rossi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082710 · Cited by 40
A novel homozygous mutation of DARS2 may cause a severe LBSL variant
Miyake, N., Yamashita, S., Kurosawa, K., Miyatake, S., Tsurusaki, Y., Doi, H., Saitsu, H., & Matsumoto, N. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01644.x · Cited by 37
Self-citationRitelli, M., Chiarelli, N., Zoppi, N., Dordoni, C., Quinzani, S., Traversa, M., Venturini, M., Calzavara-Pinton, P., & Colombi, M. (2015) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.11.005 · Cited by 37
Voermans, N. C., Kempers, M., Lammens, M., van Alfen, N., Janssen, M. C., Bönnemann, C., van Engelen, B. G., & Hamel, B. C. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35232 · Cited by 36
Mendoza‐Londono, R., Chitayat, D. A., Kahr, W. H. A., Hinek, A., Blasér, S., Dupuis, L., Goh, E. S., Badilla‐Porras, R., Howard, A., Mittaz, L., et al. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35339 · Cited by 36
Self-citationStachtea, X. N., Tykesson, E., Kuppevelt, T. H. V., Feinstein, R. E., Malmström, A., Reijmers, R. M., & Maccarana, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140279 · Cited by 37
Mizumoto, S., Kosho, T., Yamada, S., & Sugahara, K. (2017) · Pharmaceuticals · doi:10.3390/ph10020034 · Cited by 38
Self-citationThe neuromuscular differential diagnosis of joint hypermobility
Donkervoort, S. C., Bönnemann, C. G., Loeys, B., Jungbluth, H., & Voermans, N. C. (2015) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31433 · Cited by 37
Tykesson, E., Hassinen, A., Zielinska, K., Thelin, M. A., Frati, G., Ellervik, U., Westergren‐Thorsson, G., Malmström, A., Kellokumpu, S., & Maccarana, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003875 · Cited by 36
Ehlers–Danlos syndrome and neurological features: a review
Savasta, S., Merli, P., Ruggieri, M., Bianchi, L., & Spartà, M. V. (2010) · Child s Nervous System · doi:10.1007/s00381-010-1256-1 · Cited by 33
Lautrup, C. K., Teik, K. W., Unzaki, A., Mizumoto, S., Syx, D., Sin, H. H., Nielsen, I. K., Markholt, S., Yamada, S., Malfait, F., et al. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1197 · Cited by 29
Self-citationSkin proteomics – analysis of the extracellular matrix in health and disease
Dengjel, J., Bruckner‐Tuderman, L., & Nyström, A. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1773261 · Cited by 28
Hellicar, J., Stevenson, N. L., Stephens, D. J., & Lowe, M. (2022) · Journal of Cell Science · doi:10.1242/jcs.258879 · Cited by 28
Mizumoto, S., Kosho, T., Hatamochi, A., Honda, T., Yamaguchi, T., Okamoto, N., Miyake, N., Yamada, S., & Sugahara, K. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.02.018 · Cited by 31
Self-citationExtracellular matrix in skin diseases: The road to new therapies
Malta, M. D., Cerqueira, M. T., & Marques, A. P. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.11.008 · Cited by 35
Visualisation of newly synthesised collagen in vitro and in vivo
Oostendorp, C., Uijtdewilligen, P. J. E., Versteeg, E. M. M., Hafmans, T. G. M., van den Bogaard, E. H. J., de Jonge, P. K. J. D., Pirayesh, A., den Hoff, J. W. V., Ernst Reichmann, A., Daamen, W. F., et al. (2016) · Scientific Reports · doi:10.1038/srep18780 · Cited by 27
Winters, K. A., Jiang, Z., Xu, W., Li, S., Ammous, Z., Jayakar, P., & Wierenga, K. J. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35613 · Cited by 26
Chemistry and Function of Glycosaminoglycans in the Nervous System
Schwartz, N. B., & Domowicz, M. S. (2014) · Advances in Neurobiology · doi:10.1007/978-1-4939-1154-7_5 · Cited by 25
Hirose, T., Mizumoto, S., Hashimoto, A., Takahashi, Y., Yoshizawa, T., Nitahara‐Kasahara, Y., Takahashi, N., Nakayama, J., TAKEHANA, K., Okada, T., et al. (2020) · Glycobiology · doi:10.1093/glycob/cwaa058 · Cited by 27
Self-citationJungmann, O., Nikolovska, K., Stock, C. M., Schulz, J.-N., Eckes, B., Riethmüller, C., Owens, R. T., Iozzo, R. V., & Seidler, D. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050809 · Cited by 24
Yoshizawa, T., Mizumoto, S., Takahashi, Y., Shimada, S., Sugahara, K., Nakayama, J., Takeda, S., Nomura, Y., Nitahara‐Kasahara, Y., Okada, T., et al. (2017) · Glycobiology · doi:10.1093/glycob/cwx099 · Cited by 27
Self-citationUehara, M., Kosho, T., Yamamoto, N., Takahashi, H. E., Shimakura, T., Nakayama, J., Kato, H., & Takahashi, J. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40507 · Cited by 24
Self-citationKosho, T., Miyake, N., Mizumoto, S., Hatamochi, A., Fukushima, Y., Yamada, S., Sugahara, K., & Matsumoto, N. (2011) · Human Mutation · doi:10.1002/humu.21586 · Cited by 22
Self-citationA new mouse model of Ehlers-Danlos syndrome generated using CRISPR/Cas9-mediated genomic editing
Nitahara‐Kasahara, Y., Mizumoto, S., Inoue, Y., Saka, S., Posadas-Herrera, G., Nakamura-Takahashi, A., Takahashi, Y., Hashimoto, A., Konishi, K., Miyata, S., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048963 · Cited by 21
Self-citationTykesson, E., Mao, Y., Maccarana, M., Pu, Y., Gao, J., Lin, C., Zaia, J., Westergren‐Thorsson, G., Ellervik, U., Malmström, L., et al. (2015) · Chemical Science · doi:10.1039/c5sc03798k · Cited by 21
Ehlers–Danlos Syndrome Associated with Glycosaminoglycan Abnormalities
Miyake, N., Kosho, T., & Matsumoto, N. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7893-1_10 · Cited by 22
Self-citationSchneeberger, P. E., von Elsner, L., Barker, E. L., Meinecke, P., Marquardt, I., Alawi, M., Steindl, K., Joset, P., Rauch, A. M., Zwijnenburg, P. J. G., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.10.007 · Cited by 21
Dermatan sulfate epimerase 1 deficient mice as a model for human abdominal wall defects
Gustafsson, R., Stachtea, X. N., Maccarana, M., Grottling, E., Eklund, E. A., Malmström, A., & Oldberg, Å. (2014) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.23300 · Cited by 19
Janecke, A. R., Baenziger, J. U., Müller, T., & Dündar, M. (2011) · Human Mutation · doi:10.1002/humu.21440 · Cited by 18
Nadafi, R., Koning, J. J., Veninga, H., Stachtea, X. N., Konijn, T., Zwiers, A., Malmström, A., den Haan, J. M. M., Mebius, R. E., Maccarana, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00206 · Cited by 16
Chemistry and Function of Glycosaminoglycans in the Nervous System
Schwartz, N. B., & Domowicz, M. S. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_5 · Cited by 17
Alterations in glycosaminoglycan biosynthesis associated with the Ehlers-Danlos syndromes
Syx, D., Delbaere, S., Bui, C., Clercq, A. D., Larson, G., Mizumoto, S., Kosho, T., Fournel‐Gigleux, S., & Malfait, F. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00127.2022 · Cited by 18
Self-citationChondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis
Dubail, J., & Cormier‐Daire, V. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.642097 · Cited by 18
Understanding the basis of Ehlers–Danlos syndrome in the era of the next-generation sequencing
Cortini, F., Villa, C., Marinelli, B., Combi, R., Pesatori, A. C., & Bassotti, A. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01894-0 · Cited by 15
Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders
Micale, L., Fusco, C., & Castori, M. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-80614-9_9 · Cited by 17
MOCHIDA, K., Amano, M., Miyake, N., Matsumoto, N., Hatamochi, A., & Kosho, T. (2016) · The Journal of Dermatology · doi:10.1111/1346-8138.13273 · Cited by 14
Self-citationKosho, T. (2013) · Current Genetics in Dermatology · doi:10.5772/55026 · Cited by 12
Self-citationThe Ehlers–Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism
Damme, T. V., Colman, M., Syx, D., & Malfait, F. (2022) · Genes · doi:10.3390/genes13020265 · Cited by 15
Minatogawa, M., Hirose, T., Mizumoto, S., Yamaguchi, T., Nagae, C., Taki, M., Yamada, S., Watanabe, T., & Kosho, T. (2022) · Human Mutation · doi:10.1002/humu.24437 · Cited by 12
Self-citationBurrows, N. (2019) · Wiley eBooks · doi:10.1002/9781119142812.ch93 · Cited by 11
Chan, W. L., Bucher, C. H., Goldes, J., Ma, A. C., Steiner, M., Willie, B. M., Mundlos, S., & Kornak, U. (2024) · Aging Cell · doi:10.1111/acel.14322 · Cited by 10
Exome sequencing of two patients in a family with atypical X‐linked leukodystrophy
Tsurusaki, Y., Okamoto, N., Suzuki, Y., Doi, H., Saitsu, H., Miyake, N., & Matsumoto, N. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01721.x · Cited by 9
Self-citation
Metadata
- Authors
- Miyake, N., Kosho, T., Mizumoto, S., Furuichi, T., Hatamochi, A., Nagashima, Y., Arai, E., Takahashi, K., Kawamura, R., Wakui, K., Takahashi, J., Kato, H., Yasui, H., Ishida, T., Ohashi, H., Nishimura, G., Shiina, M., Saitsu, H., Tsurusaki, Y., Doi, H., Fukushima, Y., Ikegawa, S., Yamada, S., Sugahara, K., & Matsumoto, N.
- Affiliations
- Yokohama City University (JP)
- Shinshu University (JP)
- Hokkaido University (JP)
- RIKEN (JP)
- Dokkyo Medical University (JP)
- Saitama Medical University (JP)
- Sapporo Medical University (JP)
- Saitama Children's Medical Center (JP)
- Tokyo Metropolitan Kiyose Children's Hospital (JP)
- Corresponding author
- Miyake, Noriko
- Matsumoto, Naomichi
- ORCID
- Miyake, Noriko
- Kosho, Tomoki
- Mizumoto, Shuji
- Furuichi, Tatsuya
- Nagashima, Yoji
- Arai, Eiichi
- Takahashi, Kazuo
- Takahashi, Jun
- Kato, Hiroyuki
- Yasui, Hiroshi
- Ishida, Tadao
- Ohashi, Hirofumi
- Nishimura, Gen
- Shiina, Masaaki
- Saitsu, Hirotomo
- Tsurusaki, Yoshinori
- Doi, Hiroshi
- Fukushima, Yoshimitsu
- Ikegawa, Shiro
- Yamada, Shuhei
- Sugahara, Kazuyuki
- Matsumoto, Naomichi
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2010-06-29
- Volume
- 31
- Issue
- 8
- Pages
- 966-974
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2097224637
- Cited by
- 156
- References
- 35
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 10 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 10 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 13 · 2013: 12 · 2012: 16
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Mutation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (20390019)
- Dokkyo Medical University
- Ministry of Health, Labour and Welfare
- Hayashi Memorial Foundation for Female Natural Scientists
- Tokyo Medical and Dental University
- Japan Society for the Promotion of Science (22790917)
- Japan Science and Technology Agency
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Keywords
- Ehlers-Danlos syndrome, loss-of-function mutations, compound heterozygosity, decorin, dermatan sulfate, chondroitin sulfate, glycosaminoglycans, collagen fibril assembly, extracellular matrix, connective tissue diseases
- MeSH terms
- Carbohydrate Sulfotransferases, Adult, Amino Acid Sequence, Child, Collagen, Ehlers-Danlos Syndrome, Female, Fibroblasts, Glycosaminoglycans, Humans, Male, Models, Biological, Molecular Sequence Data, Mutation, Pedigree, Proteoglycans, Sulfotransferases, Signal Transduction, Transforming Growth Factor beta, Extracellular Matrix Proteins, Dermis, Decorin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
